BioAge Labs Bulls Claim the Options Tape Ahead of Q1 Print

[BioAge Labs](/s/us/bioa) heads into its Q1 earnings today with options traders firmly positioned on the bullish side — an unusually clean read for a small-cap biotech.

The clearest signal is the put/call ratio. At 0.36, it is running well below the 20-day average of 1.02, roughly one standard deviation beneath the norm. That marks a sharp reversal from April, when the PCR was running above 3.0…